杏輝藥品工業股份有限公司

杏輝藥品工業股份有限公司 is a declared insider of 杏國, with filings sourced from TWSE / TPEx (MOPS). Between 3 September 2020 and 1 July 2021, the trades on record add up to 8 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 1 July 2021 with a transaction in 杏國. Half of the filings or more reach the TWSE / TPEx (MOPS) feed on the day of the trade. This delay matters because a trade only becomes useful information once it is public. This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.